A Study of Different Durations of Treatment With Grazoprevir (MK-5172) in Combination With Ribavirin in Participants With Chronic Hepatitis C (MK-5172-039)
Clinical trial NCT01716156 · COMPLETED
Trial details
- NCT number
- NCT01716156
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-18
- Primary completion
- 2013-12-09
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.